Be Aware of SGLT2 Inhibitor Risks
SGLT2 inhibitor (empagliflozin, etc) risks will be back in the spotlight...due to recent label changes.
These meds are getting more use now that most have proven CV benefits...despite usually costing about $500/month.
Be familiar with how to manage SGLT2 inhibitor risks.
Practical advice for a better career, with unlimited access to CE
Hospital Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote